This increase in aromatase activity and subsequently estrogen levels in adipose tissue is proposed to be one of the main causal factors in the substantial increased likelihood that women classified as obese will develop breast cancer (Bulun et al., 2005). Here, CYP19A1 is linked to breast cancer.